Projects

Sanctioned Research Projects 

  

S.No

Title of the Project

PI/Co-PI

File No.

Name of Division and funding agency (DST/DBT …..)

Amount sanctioned 

   

1

Nitric oxide donating acridones as inhibitors of doxorubicin efflux in cancer cells and their membrane perturbing studies

Dr.V.V.S.Rajendra Prasad

58/66/2012-BMS/OL

ICMR

2052000

   
2 Development of Nitric oxide releasing Quinoline derivatives as inhibitors of doxorubicin resistance in cancer cells Dr.V.V.S.Rajendra Prasad VID&P/623/2018-19/TDT DST 14100000    
3 Cultivation And Production Of Spirulina To Combat Malnutrition And To Empower The Household And Entrepreneurs Dr. Vanitha    DST 6000000     

STATUS OF GRANTS RECEIVED FOR COMPLETED PROJECTS  AS ON 22.01.2018 (VIPER)

S.No.

Title of the Project

PI File No. 

Name of Division and funding agency (DST/DBT …..)

 Status    

1

Encapsulation of Gold Nanoparticle-based Doxorubicin Prodrug with dual responsive, biodegradable polymers to enhance the cytotoxicity of Doxorubicin against Multidrug-Resistant (MDR) Human Breast Cancer Cells 

Dr.V.V.S.Rajendra Prasad  

ICMR

Under Review    

2

Advances in mammalian in-vitro cell cultural techniques and functional applications

Dr.V.V.S.Rajendra Prasad  

AICTE

Under Review     

STATUS OF GRANTS RECEIVED FOR ONGOING PROJECTS  AS ON 30.10.2019 (VIPER) 

S.No.

Title of the Project

PI/Co-PI

File No.

Name of Division and funding agency (DST/DBT …..)

 Amount sanctioned    

1

In-silico optimization and synthesis of novel andragrapholade analogues as PI3K Inhibitors

Mr.Y.Viswanadham

3-2-2-56/2019

ICMR

4,67,400    
2 ”Development and Characterization of letrozole loaded polymer based nanoparticulate formulations to induce programmed cellular death in breast cancers: in-vitro&in-vivo evaluation studies”. Mrs M Sandhya 2/2/ I 7/20 1 9,4\CD-l ll ICMR 13,66000    

STATUS OF GRANTS RECEIVED FOR COMPLETED PROJECTS  AS ON 20.10.2019 (VIPER)

S.No.

Title of the Project

PI

File No.

Name of Division and funding agency (DST/DBT …..)

Date of completion / status TOTAL Whether final UC / SE & Project completion report has been submitted (If yes, mention date)

1

Formulation evaluation and optimization of floating drug delidery system of antihypertensive drugs.

Mrs S.Sandhyarani

SR/WOS-A/CS-77/2012

DST

 20.07.2016/Completed 21,80,000 I & II UC/SE submitted /Final UC Not Submitted

2

Optimization and evaluation of prazosin floating microspheres using response surface methodology

Dr.K.Vanitha

 SR/WOS-A/LS-496/2012

DST 

 02.06.2016 Completed  21,20000  I, II & III UC/SE submitted

3

Design and synthesis of quinoline tagged acridones as reverters of multidrug resistance (MDR) in cancer

Dr.V.V.S.Rajendra Prasad

1-15/RIFD/CA/11/2011-12

AICTE 

  02-03-014/Completed  9,00,000  Final UC & PCC submitted on 10.03.2014

4

Design and Synthesis of Nitric Oxide Donating Phenoxazine Derivatives as Reverters of Multidrug Resistance (MDR) in Cancer cells

Dr.V.V.S.Rajendra Prasad

SR/FT/LS-175/2009

SERB, DST

 23-09- 014/Completed  18,02,2000  Final UC & PCC submitted on 02.03.2015

5


Cytotoxicity studies of some novel fluoro acridone derivatives against sensitive
and resistant cancer cell lines and their mechanistic studies

Dr.V.V.S.Rajendra Prasad

SR/ITS/3737/2012-13

 

DST-Travel Grant 

 07-12-2012/Completed  1,39,000 Final UC submitted on 5.12.2012

6

Nitric oxide releasing acridone carboxamide derivatives as reverters
of doxorubicin resistance in MCF7/Dx cancer cells

Mr.G.Deepak Reddy/Dr.VVS.Rajendra Prasad

SERB/F/7397/2014-15

DST-Travel Grant

10-12-2014/Completed 1,35,000 Final UC  submitted on 14.12.2014

7

Projects under Institute - Industry Innovation Cell (IIIC)

Dr. Ramesh

NA

MSME (FMC)

10-02-2012/Completed 5,29,000 Final UC  submitted on 30.03.2012

8

Seminar grant

Dr.Ramesh

NA

DST

10-02-2012/Completed 75,000 Final UC  submitted on 10.03.2012

9

Seminar grant

Dr.Ramesh

NA

DST

March 2016/Completed 50,000 Final UC  submitted on March-2016

10

 Neuroprotective activity of polyherbal formulation aganist transient global ischemia induced brain damage in normal and alloxan induced diabetic rats  Mrs. Santosha  SR/WOS-A/LS-491/2012  DST  March 2017/Completed  24,60,000  Final UC  submitted on March-2017

11

Role of individual isoforms of Phosphoinositide 3-kinase (PI3K) inhibitors and non-selective inhibitors in in vivo models of Alzheimer's disease (AD). Dr.Ramesh SR/CSI/107/2012(G) DST October 2017/Completed 48,92,800 Final UC will be submitted in March 2018

12

Structural insights to inhibit Epidermal Growth Factor Receptor (EGFR) dimerization & activation: Panitumumab induced Conformational study Mr.D.Appaji/Dr.VVS.Rajendra Prasad 6242-P55/RGCB/PBD/DBT/APDK/2015 DBT 01-09-2018/Completed 24,75,480 Final UC Submitted

13

Binding kinetics & Interaction analysis of Pertuzumab in complex with isolated extracellular domain II (sHER2 dII) & domain IV (sHER2 dIV) of Human Epidermal growth factor receptor 2(sHER2): Structural Implications in the inhibition of HER2/HER3 mediated dimerization and activation. Mr.D.Appaji YSS/2014/002005 SERB, DST 31.01.2019/Completed  27,25,000 Final UC Submitted

 

 

 

  


Print   Email